EYPT vs MDT · rev $1.2M vs P/E 21, rev $36.36B
Eyepoint Pharmaceuticals Inc (EYPT) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
EYPT currently screens at market cap $1.10B. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the EYPT and MDT stock pages for the full models.
Not investment advice.